Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2026-03-16 00:00:00 ET · period of report 2026-03-12 · accession 0001914879-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-16 | 2026-03-12 | MYGN | Fox Jennifer Lynne | CLO | A - Grant | $0.00 | +195.9K | 316.4K | +163% | $0 | |
| 2026-03-16 | 2026-03-13 | MYGN | Fox Jennifer Lynne | CLO | F - Tax | $4.66 | -5,995 | 310.4K | -2% | -$27.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-12 | A | A | 195,876 | $0.00 | 316,357 | D | — | — | (F1) Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. |
| 2 | Common | Common Stock | 2026-03-13 | F | D | 5,995 | $4.66 | 310,362 | D | — | — | (F2) Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026. |